Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opus Genetics (IRD) Current Assets (2021 - 2024)

Opus Genetics (IRD) has disclosed Current Assets for 8 consecutive years, with $54.2 million as the latest value for Q3 2023.

  • On a quarterly basis, Current Assets rose 272.14% to $54.2 million in Q3 2023 year-over-year; TTM through Sep 2023 was $54.2 million, a 272.14% increase, with the full-year FY2022 number at $49.0 million, up 87.92% from a year prior.
  • Current Assets was $54.2 million for Q3 2023 at Opus Genetics, up from $43.5 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $54.2 million in Q3 2023 to a low of $12.1 million in Q1 2021.
  • A 3-year average of $30.1 million and a median of $25.2 million in 2021 define the central range for Current Assets.
  • Peak YoY movement for Current Assets: plummeted 37.22% in 2022, then soared 272.14% in 2023.
  • Opus Genetics' Current Assets stood at $26.1 million in 2021, then soared by 87.92% to $49.0 million in 2022, then increased by 10.62% to $54.2 million in 2023.
  • Per Business Quant, the three most recent readings for IRD's Current Assets are $54.2 million (Q3 2023), $43.5 million (Q2 2023), and $45.4 million (Q1 2023).